1. Management of Locoregional Rectal Cancer.
- Author
-
Willett CG
- Subjects
- Antineoplastic Combined Chemotherapy Protocols standards, Chemoradiotherapy methods, Chemoradiotherapy standards, Disease-Free Survival, Fluorouracil standards, Fluorouracil therapeutic use, Humans, Leucovorin standards, Leucovorin therapeutic use, Medical Oncology standards, Neoadjuvant Therapy methods, Neoadjuvant Therapy standards, Neoplasm Staging, Organoplatinum Compounds standards, Organoplatinum Compounds therapeutic use, Proctectomy methods, Rectal Neoplasms diagnostic imaging, Rectal Neoplasms mortality, Rectal Neoplasms pathology, Rectum diagnostic imaging, Rectum pathology, Rectum surgery, Societies, Medical standards, United States epidemiology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Practice Guidelines as Topic, Proctectomy standards, Rectal Neoplasms therapy, Watchful Waiting standards
- Abstract
The NCCN Guidelines for Rectal Cancer are now more closely aligned with those for colon cancer. A new MRI-based definition of the rectum has been included and the use of MRI in staging has been elevated in importance. There is a new emphasis on neoadjuvant therapy, especially the concurrent use of chemotherapy and radiotherapy. One of the biggest changes is more acceptance of an observational approach-"watch and wait, nonoperative management"-for select patients experiencing a complete clinical response with no evidence of residual disease after neoadjuvant therapy., (Copyright © 2018 by the National Comprehensive Cancer Network.)
- Published
- 2018
- Full Text
- View/download PDF